ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Lung transplantation"

  • 2021 American Transplant Congress

    Use of Granulocyte Colony Stimulating Factor After Lung Transplantation is Not Associated with Increased Likelihood of Acute Cellular Rejection

    S. Fredrick1, C. Iasella2, L. Sacha3, R. Rivosecchi3, M. Morrell3, P. Sanchez3, J. Pilewski3, M. Snyder3, J. McDyer3, C. Moore3

    1University of Rochester Medical Center, Rochester, NY, 2University of Pittsburgh School of Pharmacy, Pittsburgh, PA, 3University of Pittsburgh Medical Center, Pittsburgh, PA

    *Purpose: The cause of neutropenia in lung transplant recipients is multifactorial, including medications, viral infections, and antecedent disease. Granulocyte colony-stimulating factor (G-CSF) is commonly used…
  • 2021 American Transplant Congress

    Donor Lymphocytes in Peripheral Blood of Patients After Lung Transplantation Comprise High Frequencies of Killer Cell Immunoglobulin-like Receptor-positive T and NK Cell Subsets

    J. F. Kühne1, A. Hitz1, K. A. Bläsing1, B. Wiegmann2, R. Bellmàs Sanz1, F. Ius2, A. Haverich2, G. Warnecke2, C. S. Falk1

    1MHH, Institute of Transplant Immunology, Hannover, Germany, 2MHH, Department for Cardiothoracic, Transplantation and Vascular Surgery, Hannover, Germany

    *Purpose: For end-stage lung diseases, lung transplantation (LuTx) is the only curative treatment option. However, acute and chronic rejections are major limitations. Thus, a deeper…
  • 2021 American Transplant Congress

    Acute Kidney Injury After Lung Transplantation: Incidence, Risk Factors and Outcomes. Results from a Monocentric Retrospective Cohort Study

    M. Gandolfo1, C. Bellincioni1, L. Morlacchi2, V. Rossetti2, F. Blasi2, P. Messa1

    1Nephrology, Ospedale Maggiore Policlinico, Milano, Italy, 2Pneumology, Ospedale Maggiore Policlinico, Milano, Italy

    *Purpose: Acute kidney Injury (AKI) occurs in more than 50% of patients after lung transplantation (LTx). Our purpose was to define incidence, risk factors and…
  • 2020 American Transplant Congress

    Impact of Ozone Exposure of Lung Donors and Recipients on All-Cause Mortality after Lung Transplant

    T. Egan1, S. Arunachalam2, C. Chang2, P. Strassle1

    1Surgery, UNC at Chapel Hill, Chapel Hill, NC, 2Institute of the Environment, UNC at Chapel Hill, Chapel Hill, NC

    *Purpose: A Belgian study found proximity to a motorway increased risk of bronchiolitis obliterans syndrome after lung transplant (LT). Using zip codes as a surrogate…
  • 2020 American Transplant Congress

    Anticipated Cost Savings of Using Lungs from Hepatitis C-Positive Lung Donors for Hepatitis C-Negative Recipients

    K. Ryland1, J. Mallea2, J. Moriarty3, L. White4, B. Borah5, J. Naessens3

    1Transplantation, Mayo Clinic, Jacksonville, FL, 2Medicine, Mayo Clinic, Jacksonville, FL, 3Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, 4Health Sciences Research, Mayo Clinic, Jacksonville, FL, 5Health Sciences Research, Mayo Clinic, Rochester, MN

    *Purpose: We assessed the cost savings generated by additional organ availability due to utilizing lungs from hepatitis-C infected donors for transplantation in comparison to existing…
  • 2020 American Transplant Congress

    Analysis of the Quality of Lung Transplantation in Mainland China During 2015- 2018

    H. Chun Xiao, L. Xiao Shan, C. Jing Yu

    Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China

    *Purpose: Lung Transplantation(LT)has been demonstrated as the only effective therapy for patients with end-stage lung diseases. This study aimed to summarize and analyze the data…
  • 2020 American Transplant Congress

    Epidemiology of Invasive Candidiasis in Lung Transplant Recipients at a Large Transplant Center

    F. J. Marco Canosa1, J. A. Morillas1, H. Hassouna2, K. Brizendine1

    1Infectious Disease Department, Cleveland Clinic Foundation, Cleveland, OH, 2Division of Infectious Disease, Spectrum Health Medical Group, Grand Rapids, MI

    *Purpose: Invasive candidiasis (IC) represents the most common fungal infection in lung transplant recipients (LTR) early post-transplant. Universal antifungal prophylaxis is frequently employed, which may…
  • 2020 American Transplant Congress

    Case Series of Belatacept for Calcineurin Inhibitor Sparing after Lung Transplantation

    H. Patel, C. R. Ensor, R. D. Davis, L. Bogar, D. Colella, M. Kildea, J. Kim, A. Satterthwaite, D. Ventura, C. Gries

    AdventHealth, Orlando, FL

    *Purpose: Belatacept is a recombinant soluble fusion protein which selectively blocks T-cell co-stimulation. It received initial FDA approval for prophylaxis of organ rejection in Epstein-Barr…
  • 2020 American Transplant Congress

    Suspected Vape Use in Lung Donor

    S. Leonard1, N. Sinha2, S. Manickavel2, S. Manickavel2

    1Division of Pulmonary, Critical Care and Sleep Medicine, University of Miami/Jackson Health System, Miami, FL, Miami, FL, 2Miami Transplant Institute, University of Miami/Jackson Health System, Miami, FL, Miami, FL

    *Purpose: E-cigarette, or vaping, product use-associated lung injury (EVALI) is a recently described disease entity prominently reported throughout many sources. Thus far, diagnosis is primarily…
  • 2020 American Transplant Congress

    Pre-Transplant Monocyte HDAC6 Expression and Risk of Primary Graft Dysfunction in Clinical Lung Transplant Recipients

    T. Akimova1, T. Zhang1, L. Wang1, J. D. Christie2, W. W. Hancock1

    1Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA

    *Purpose: Lung transplantation (Tx) in ~30% of cases is subject to primary graft dysfunction (PGD), the severe acute lung injury that occurs within 72 hours…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 42
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences